News Focus
News Focus
Followers 28
Posts 5148
Boards Moderated 0
Alias Born 05/24/2006

Re: DewDiligence post# 937

Tuesday, 04/08/2008 5:22:15 AM

Tuesday, April 08, 2008 5:22:15 AM

Post# of 1367
Kamada was granted new (in addition to congenital emphysema and CF) Orphan drug designation by the FDA, for its inhaled AAT for the treatment of Bronchiectasis (currently undergoing Phase II clinical trials).

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now